ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Non interest income is the income earned by banks through activities through lending, advising, consulting etc. Isis Pharmaceuticals's non interest income for the three months ended in Dec. 2013 was $0.0 Mil. Its non interest income for the trailing twelve months (TTM) ended in Dec. 2013 was $0.0 Mil.
Income earned by banks through activities through lending, advising, consulting etc. They are not from the financial assets that banks own.
Isis Pharmaceuticals Non Interest Income for the trailing twelve months (TTM) ended in Dec. 2013 was 0 (Mar. 2013 ) + 0 (Jun. 2013 ) + 0 (Sep. 2013 ) + 0 (Dec. 2013 ) = $0.0 Mil.
Isis Pharmaceuticals Annual Data
Isis Pharmaceuticals Quarterly Data